A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment
Authors:
- Amaia AzquetaAmaia Azqueta
- Leire ArbillagaLALeire Arbillaga
- Gisela PachónGPGisela Pachón
- Marta CascanteMCMarta Cascante
- Edmond E CreppyECEdmond E Creppy
- Adela López de CerainACAdela López de Cerain
- 1 June 2007
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 168 (2) , 95-105
Abstract
No abstract availableKeywords
Funding Information
- Universidad de Navarra
This publication has 46 references indexed in Scilit:
- The hypoxic core: a possible answer to the cancer paradoxBiochemical and Biophysical Research Communications, 2002
- Hypoxia as a target for combined modality treatmentsEuropean Journal of Cancer, 2002
- Prodrug strategies in cancer therapyEuropean Journal of Medicinal Chemistry, 2001
- Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategiesMolecular Medicine Today, 2000
- Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatinBritish Journal of Cancer, 1999
- Bioreductive therapies: an overview of drugs and their mechanisms of actionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- Potential bioreductive alkylating agents. 1. Benzoquinone derivativesJournal of Medicinal Chemistry, 1972